Marché de la détection de la tuberculose latente – Analyse des tendances et de la croissance | Année de prévision 2031

  • Report Code : TIPRE00014239
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 137
Buy Now

Le marché de la détection latente de la tuberculose devrait atteindre 1 684,86 millions de dollars US en 2027 contre 1 131,82 millions de dollars US en 2019. Le marché devrait croître avec un TCAC de 5,2 % entre 2020 et 2027.



La croissance du marché est attribuée à la prévalence croissante de la tuberculose et aux initiatives gouvernementales visant à promouvoir la détection de la tuberculose. Cependant, la tuberculose multirésistante (MDR-TB) est susceptible d'entraver la croissance du marché de la détection latente de la tuberculose dans une certaine mesure.



Marchés régionaux lucratifs pour la détection latente de la tuberculose

< /h3>

Aperçu du marché



Initiatives gouvernementales pour promouvoir la détection de la tuberculose



La maladie affecte de manière disproportionnée les personnes pauvres, vulnérables, sous-alimentées et marginalisées dans le monde entier. Des preuves provenant de diverses sources telles que l'Organisation mondiale de la santé (OMS) et les Nations Unies (ONU) montrent que des pays comme l'Inde et l'Indonésie en Asie-Pacifique sont très peuplés de patients atteints de tuberculose. Ainsi, les organismes gouvernementaux de ces pays entreprennent et adoptent certains programmes et initiatives pour contenir la maladie. Par exemple, le Plan stratégique national indien (NSP) qui vise l'élimination de la tuberculose a été établi de 2017 à 2025 ; il institue plusieurs groupes de soutien aux patients et des mesures de protection ainsi que la fourniture de tests de diagnostic et de traitement gratuits de la tuberculose aux Indiens. En outre, en mars 2018, le gouvernement indien, en association avec la Direction des services généraux de santé, a introduit un nouveau programme connu sous le nom de «Nikshay Poshak Yojna” qui comprenait la fourniture d'un soutien nutritionnel aux patients souffrant de tuberculose en Inde. De même, un autre système connu sous le nom de transfert direct des avantages (DBT) a été introduit pour les patients souffrant de tuberculose. Cette politique implique un transfert direct d'argent sur le compte de la victime destiné aux tests de diagnostic de la tuberculose, aux traitements et aux coûts des médicaments.



De plus, les pays occidentaux tels que les États-Unis, le Royaume-Uni et le Canada accordent une importance considérable à la lutte contre TB en entreprenant divers programmes de financement. Le gouvernement américain est le plus grand donateur du Fonds mondial de lutte contre le sida, la tuberculose et le paludisme. Le financement américain des efforts mondiaux de lutte contre la tuberculose s'élèverait à 321 millions de dollars américains en 2020. Ainsi, l'aide financière et médicale des gouvernements pour lutter contre la maladie et promouvoir le diagnostic de la tuberculose fournit un scénario lucratif pour la croissance du marché.



Aperçus basés sur les tests



Sur la base des tests, le marché de la détection de la tuberculose latente a été segmenté en test cutané à la tuberculine (TST) et en test de libération d'interféron gamma (IGRA). En 2019, le segment Interferon Gamma Released Assay (IGRA) représentait la part la plus élevée du marché et devrait conserver sa part dominante. En outre, le segment similaire devrait connaître la croissance la plus rapide du marché en raison de la précision obtenue grâce à ces tests. Le test TLIG présente de nombreux avantages par rapport au TST en ce qu'il n'est pas nécessaire que le patient revienne pour l'évaluation des résultats du test. Les TLIG actuelles ne réagissent pas de manière croisée avec la plupart des mycobactéries non tuberculeuses, y compris les souches Bacille Calmette-Guérin (BCG).



Marché de la détection latente de la tuberculose, par test - 2019 et 2027




Informations basées sur l'utilisateur final



En fonction de l'utilisateur final, le marché de la détection de la tuberculose latente est segmenté en hôpitaux, centres de diagnostic, laboratoires et autres. Le segment des hôpitaux détenait la plus grande part du marché en 2019. De plus, on estime que le même segment enregistrera le TCAC le plus élevé du marché au cours de la période de prévision.



Perspectives stratégiques



Le acteurs du marché de la détection de la tuberculose latente tels que QIAGEN, BioMeriux SA, F. Hoffmann La-Roche Ltd., BD, ARKRAY, Inc., Abbott, Serum Institute of India Pvt. Ltd, Oxford Immunotec Ltd, Lionex GmbH ont adopté plusieurs stratégies organiques et inorganiques pour améliorer leurs revenus et leur position sur le marché. Par exemple, en septembre 2020, Oxford Immunotec a reçu l'approbation de la FDA pour autoriser l'utilisation du test T-SPOT.TB chez les enfants de deux ans et plus. Cela aidera à répondre aux besoins des patients pédiatriques pour la prise en charge de la tuberculose



Marché de la détection latente de la tuberculose par test




  • Test cutané à la tuberculine (TST)

  • Interféron Gamma Released Assay (IGRA)

Marché de la détection de la tuberculose latente - par utilisateur final




  • Hôpitaux

  • Centres de diagnostic
  • < li>Laboratoires
  • Autres

Marché de la détection de la tuberculose latente - par géographie




  • Amérique du Nord

    • États-Unis
    • Canada

    • Mexique


  • Europe

    • France

    • Allemagne
    • < li>Italie
    • Royaume-Uni

    • Espagne

    • Reste de l'Europe


  • Asie-Pacifique (APAC)< ul>
  • Chine

  • Inde

  • Corée du Sud

  • Japon

  • Australie

  • Reste de l'Asie-Pacifique


  • Moyen-Orient et Afrique (MEA)

    • Afrique du Sud

    • Arabie saoudite

    • EAU
    • Reste du Moyen-Orient et Afrique


  • Amérique du Sud et centrale

    • Brésil

    • Argentine

    • Reste de l'Amérique du Sud et centrale


  • Profils des entreprises




    • QIAGEN

    • BioMeriux SA
    • F. Hoffmann La-Roche Ltd.

    • BD

    • ARKRAY, Inc.

    • Abbott

    • Serum Institute of India Pvt. Ltée

    • Oxford Immunotec Ltée

    • Lionex GmbH

    Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    The List of Companies - Latent TB Detection Market

    1. QIAGEN
    2. BioMeriux S.A.
    3. F. Hoffmann La-Roche Ltd.
    4. BD
    5. ARKRAY, Inc.
    6. Abbott
    7. Serum Institute of India Pvt. Ltd
    8. Oxford Immunotec Ltd
    9. Lionex GmbH

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Related Reports